Search database
Filter
13
Text search: G-Finder
Featured
Language
Document type
Studies & Reports
7
Strategic & Response Plan
2
No document type
2
Manuals
1
Guidelines
1
Countries / Regions
Global
4
Latin America and the Carribbean
1
Authors & Publishers
World Health Organization (WHO)
2
390: 898&ndash
1
912
1
A. Gheorghe
1
Access to Medicine Foundation
1
BMJ Global Health
1
Burri, E.
1
CA J, Kumar P V, Kandi V,
1
DNDi 
1
G-Finder
1
hler, Oliver Razum, Jean-Olivier Schmidt
1
Ilona Kickbusch, Christian Franz, Anna Holzscheiter, Iris Hunger, Albrecht Jahn, Carsten K&ouml
1
K. Hauck
1
Lancet 2017&#59
1
MDPI
1
O’Neill, J.
1
Quirk, E.J.
1
Review on Antimicrobial Resistance
1
UNITAID Secretariat, World Health Organization
1
World Health Organisation (WHO)
1
World Health Organisation WHO
1
World Health Organization WHO
1
Publication Years
Category
Public Health
1
Countries
1
Clinical Guidelines
1
Pharmacy & Technologies
1
Toolboxes
NTDs
3
Health Financing Toolbox
2
Malaria
2
Global Health Education
1
AMR
1
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to preve ... more
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife ... more
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in- come countries (LMICs). While the COVID-19 pan ... more
Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.
Cureus 16(2): e53933. DOI 10.7759/cureus.53933
2nd edition
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting ... more
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for additional funding and funders but also for the need to understand the current funding ... more
Printed Edition pdf
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated ... more
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backbone of malaria treatments after failures of chloroquine and sulfadoxine-pyrimethamine​ – has now b ... more